Fineline Cube

Follow:
14433 Articles
Kangtai Biological Gains NMPA Approval for Trivalent Influenza Vaccine Clinical Trial
CompanyDrug

Kangtai Biological Gains NMPA Approval for Trivalent Influenza Vaccine Clinical Trial

Zhifei Biological's Adult and Adolescent DTaP Vaccine Gains NMPA Trial Approval
CompanyDrug

Zhifei Biological’s Adult and Adolescent DTaP Vaccine Gains NMPA Trial Approval

RemeGen Inks Licensing Deal With Santen China for RC28-E Eye Disease Drug
CompanyDigital

RemeGen Inks Licensing Deal With Santen China for RC28-E Eye Disease Drug

MicroPort CardioFlow's Alwide Plus Wins EU CE Mark for Heart Valve Procedures
CompanyMedical Device

MicroPort CardioFlow’s Alwide Plus Wins EU CE Mark for Heart Valve Procedures

Mabwell's Innovative CDH17-Targeted ADC 7MW4911 Receives FDA Clinical Trial Approval
CompanyDrug

Mabwell’s Innovative CDH17-Targeted ADC 7MW4911 Receives FDA Clinical Trial Approval

Hengrui Pharma's Hetrombopag Olamine Accepted by NMPA for Chemotherapy-Induced Thrombocytopenia
CompanyDrug

Hengrui Pharma’s Hetrombopag Olamine Accepted by NMPA for Chemotherapy-Induced Thrombocytopenia

WuXi XDC Reports Strong H1 2025 Growth With 62.2% Revenue Increase
Company

WuXi XDC Reports Strong H1 2025 Growth With 62.2% Revenue Increase

Genentech to End $2B Collaboration With Adaptive Biotechnologies on T-Cell Therapies
CompanyDeals

Genentech to End $2B Collaboration With Adaptive Biotechnologies on T-Cell Therapies

Henlius Partners with GeneQuantum on HER2-Targeted ADC GQ1005 Development
CompanyDeals

Henlius Partners with GeneQuantum on HER2-Targeted ADC GQ1005 Development

Acotec Scientific's Micro-Guidewire Receives Beijing Medical Products Administration Approval
CompanyMedical Device

Acotec Scientific’s Micro-Guidewire Receives Beijing Medical Products Administration Approval

Skyhawk Therapeutics Collaborates with Merck on RNA-Targeting Small Molecules for Neurological Diseases
CompanyDeals

Skyhawk Therapeutics Collaborates with Merck on RNA-Targeting Small Molecules for Neurological Diseases

Sichuan Biokin's Iza-Bren Granted FDA Breakthrough Therapy Designation for NSCLC
CompanyDrug

Sichuan Biokin’s Iza-Bren Granted FDA Breakthrough Therapy Designation for NSCLC